CliffBio
small molecule

LOTRIMIN ULTRA

BUTENAFINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyBayer Healthcare →See this company's full patent-cliff portfolio

Drug detail

Brand nameLOTRIMIN ULTRA
Active ingredientBUTENAFINE HYDROCHLORIDE
Strength1%
Dosage formCREAM
RouteTOPICAL
ModalitySmall molecule
FDA approvalDecember 2001
Marketing statusOTC

More from Bayer Healthcare

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.